Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Amita Sapru"'
Autor:
Catherine Cohet, Brigitte Cheuvart, Leentje Moerman, Dan Bi, Adrian Caplanusi, Mallesh Kariyappa, Sanjay Lalwani, Monjori Mitra, Amita Sapru, Shruti Saha, P.V. Varughese, Rajeev Zachariah Kompithra, Sanjay Gandhi
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4646-4653 (2021)
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6–10
Externí odkaz:
https://doaj.org/article/5d35f76d2617450b9901c97811e1abfb
Autor:
Ashish Bavdekar, Nandini Malshe, Latha Ravichandran, Amita Sapru, Anand Kawade, Sanjay Lalwani, Sonali Palkar, Neeta Hanumante, Bhagwat Gunale, Dhananjay Kapse, Amol Chaudhari, Tara Miller, Laura Saganic, Courtney Jarrahian, Sarah McGray, Darin Zehrung, Prasad S. Kulkarni
Publikováno v:
Contemporary Clinical Trials Communications, Vol 14, Iss , Pp - (2019)
Introduction: We conducted a randomized, observer-blind, non-inferiority, parallel-group clinical study of diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b conjugate (pentavalent) vaccination of infants in India. Goals w
Externí odkaz:
https://doaj.org/article/49d13e3a0b3f44c5bd46768819704fef
Autor:
Rajeev Zachariah Kompithra, Dan Bi, Amita Sapru, Adrian Caplanusi, Shruti Saha, Leentje Moerman, Brigitte Cheuvart, Sanjay Gandhi, Mallesh Kariyappa, Sanjay Lalwani, Catherine Cohet, Monjori Mitra, P.V. Varughese
Publikováno v:
Human Vaccines & Immunotherapeutics. 17:4646-4653
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6-10 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86bdf4be4266e2b38f3c6d5badc7ee0
https://doi.org/10.1080/21645515.2021.1960136
https://doi.org/10.1080/21645515.2021.1960136
Autor:
Balasubramanian Sundaram, Daniel A. Scott, Rohit Chand, Amita Sapru, Jugesh Chhatwal, Stephen Lockhart, Kevin Yi, Bhaskar Shenoy, Suresh Suroju
Publikováno v:
Vaccine. 39(37)
Purpose The 13-valent pneumococcal conjugate vaccine (PCV13) was recently approved in India for the prevention of pneumococcal disease in children aged 6 to 17 years based on global data as well as immunogenicity and safety findings from a phase 3 st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2309f4172cd2ed885d3285367af5aafd
https://pubmed.ncbi.nlm.nih.gov/34366142
https://pubmed.ncbi.nlm.nih.gov/34366142
Publikováno v:
Indian Pediatrics. 52:687-690
To assess immunogenicity of a single dose of live attenuated hepatitis A vaccine in Indian children, ten years after immunization.Of 143 children vaccinated in 2004, 121 children were evaluated in 2014, clinically and for anti-HAV antibodies.13 child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ef4faa19006bf00dfd4ce098af3d44
https://doi.org/10.1007/s13312-015-0697-8
https://doi.org/10.1007/s13312-015-0697-8
Autor:
S. S. Naik, Anand Pandit, Prasad S. Kulkarni, Ashish Bavdekar, Prajakt Barde, Moreshwar Patwardhan, Amita Sapru
Publikováno v:
Human Vaccines. 7:941-944
Because of the high mother-to-infant transmissibility of hepatitis B (HB) infection, neonatal vaccination is necessary, but the further doses of HB vaccines can be combined with conventional diphtheria-tetanus-whole cell pertussis (DTPw) vaccines. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365af24a034dd643c49027207ec1a479
https://doi.org/10.4161/hv.7.9.15994
https://doi.org/10.4161/hv.7.9.15994
Autor:
Bhagwat Gunale, Amita Sapru, Ashish Bavdekar, Anand Pandit, Pradeep D’costa, Somnath Mangrule, Ashwin Belludi Yajaman, Shampur Narayan Madhusudana, Prasad S. Kulkarni
Publikováno v:
Vaccine. 31(24)
Background Rabies is 100% fatal but preventable with modern vaccines and immunoglobulins. There is a huge demand for rabies vaccines in developing countries of Asia and Africa. We have developed a new purified vero cell rabies vaccine (PVRV) and eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec2833e74ab6026150bba137bd5d851
https://pubmed.ncbi.nlm.nih.gov/23583817
https://pubmed.ncbi.nlm.nih.gov/23583817
Publikováno v:
Indian pediatrics. 48(2)
A long-term immunogenicity study of a single dose live attenuated H2 strain hepatitis A vaccine is being conducted in healthy Indian children at KEM Hospital, Pune. 131 of the original 143 children vaccinated in 2004, were evaluated for anti-HAV anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9754a83047f3dc94cd2e78087c58c0ec
https://pubmed.ncbi.nlm.nih.gov/21169655
https://pubmed.ncbi.nlm.nih.gov/21169655
Publikováno v:
Journal of tropical pediatrics. 53(5)
Hepatitis B infection is very common in infants, especially in countries with limited resources. Hepatitis B vaccination is recommended in the routine immunization schedules in many countries, including India. We compared immunogenicity and reactogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89108a1f23cbd21128f9d629d0b19327
https://pubmed.ncbi.nlm.nih.gov/17478542
https://pubmed.ncbi.nlm.nih.gov/17478542
Autor:
Sheila Bhave, Suparna Chatterjee, Amita Sapru, Ganesh Kadhe, Sucheta Roy, Amey Mane, Apurba Ghosh, Monjori Mitra, Nisha Bhattacharya
Publikováno v:
Vaccine: Development and Therapy. :1
Sheila Bhave,1 Apurba Ghosh,2 Amita Sapru,1 Monjori Mitra,2 Suparna Chatterjee,3 Nisha Bhattacharya,2 Ganesh Kadhe,4 Amey Mane,4 Sucheta Roy41Department of Pediatrics, KEM Hospital Research Centre, Pune, Maharashtra, India; 2Department of Pediatrics,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc2c203926950e73004091bb24d27b7
https://doi.org/10.2147/vdt.s52736
https://doi.org/10.2147/vdt.s52736